title: Embryonic striatal grafts restore neuronal activity of the globus pallidus in a rodent model of Huntington's disease.
abstract: It has been demonstrated in rats that embryonic striatal grafts placed in the excitotoxically lesioned striatum establish neuronal connections with the host globus pallidus. In order to determine whether the morphologically verified connections between the grafts and host are functional, the present study investigated the effects of embryonic striatal grafts on changes in the neuronal activity of the globus pallidus in rats with quinolinic acid-induced striatal lesions. The activity of pallidal neurons was determined by use of quantitative cytochrome oxidase histochemistry and an electrophysiological technique. Striatal lesions induced an increase in both the cytochrome oxidase activity and the spontaneous firing rate of the globus pallidus ipsilateral to the lesions. Grafts derived from the lateral ganglionic eminence, but not the medial ganglionic eminence, reversed the lesion-induced increase in the cytochrome oxidase activity of the globus pallidus with concomitant reduction of apomorphine-induced rotational asymmetry. The lateral ganglionic eminence grafts also attenuate the increase in the firing rate of pallidal neurons in rats with striatal lesions. The present results provide evidence that striatal lesions lead to the loss of a tonic inhibitory input to the globus pallidus with consequent increase in the activity of pallidal neurons, and that intrastriatal striatal grafts reverse the altered activity of pallidal neurons. The findings strongly suggest that embryonic striatal grafts functionally repair the damaged striatopallidal pathway.
authors: Department of Neurological Surgery, Wakayama Medical College, Japan.
authors: N
authors: N
authors: Nakao
authors: M
authors: M
authors: Ogura
authors: K
authors: K
authors: Nakai
authors: T
authors: T
authors: Itakura
mesh_terms: D000200:Action Potentials / Q000502:physiology; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D016380:Brain Tissue Transplantation; D003342:Corpus Striatum / Q000637:transplantation*; D004195:Disease Models, Animal; D003576:Electron Transport Complex IV / Q000378:metabolism; D004594:Electrophysiology; D016332:Fetal Tissue Transplantation; D005917:Globus Pallidus / Q000166:cytology / Q000502:physiology*; D006816:Huntington Disease / Q000601:surgery*; D008297:Male; D009474:Neurons / Q000201:enzymology; D017378:Quinolinic Acid; D051381:Rats; D017207:Rats, Sprague-Dawley; D012399:Rotation
chemical_list: D000978:Antiparkinson Agents; D003576:Electron Transport Complex IV; D017378:Quinolinic Acid; D001058:Apomorphine